Understand the source comparison
Peptides vs Standard Recovery: Outcomes Comparison
Tendon-bone healing (ACL repair) 8–12 weeks to weight-bearing 5–8 weeks to weight-bearing 30–40% faster return to activity; documented in 2024 AJSM study Surgical site infection rate 2–5% (varies by procedure) 0.8–2.1% with BPC-157/TB-500 BPC-157's antimicrobi
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Tendon-bone healing (ACL repair)
- 8–12 weeks to weight-bearing
- 5–8 weeks to weight-bearing
- 30–40% faster return to activity; documented in 2024 AJSM study
- Surgical site infection rate
- 2–5% (varies by procedure)
- 0.8–2.1% with BPC-157/TB-500
- BPC-157's antimicrobial peptide properties reduce bacterial colonization
- Scar tissue quality (abdominal surgery)
- 60–70% develop adhesions requiring intervention
- 30–40% adhesion rate with TB-500
- Preserved tissue plane mobility; reduced need for adhesiolysis
- Inflammatory marker resolution (CRP, IL-6)
- Returns to baseline by day 14–21
- Returns to baseline by day 7–10
- Faster transition to proliferative healing phase
- Collagen type I:III ratio at 6 weeks
- 1.2:1 (suboptimal remodeling)
- 2.1:1 (near-native architecture)
- Higher type I ratio = stronger, more organized tissue
- Professional Assessment
- Recovery driven by baseline biology and surgical technique. Outcome variability high
- Peptide signaling removes key rate-limiters. Outcome variability reduced; healing quality improves independent of patient baseline health